BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 14, 2001
View Archived Issues
Bentley and Pfizer enter R&D agreement for enhanced drug delivery
Read More
Patient enrollment completed for phase II study of IPL-576092 in mild asthma
Read More
FDA approves Herceptin labeling changes to add survival data
Read More
Orphan drug status awarded to bryostatin 1 for combination therapy of esophageal cancer
Read More
Approvable letter expands use and formulations of Vivelle-Dot
Read More
Replacement therapy for congenital protein C deficiency now available in Europe
Read More
Relief of oral mucositis pain on iseganan correlated with other outcome measures
Read More
Efficacy of ARGENT-Epo regulated gene expression therapy demonstrated in mouse model
Read More
Successful repeated administration of MaxAdFVIII achieved in animal studies
Read More
Interneuron highlights positive year-end developments
Read More
First human study demonstrates safety of heparin/SNAD and potential efficacy
Read More
Humanized anti-HM1.24 MAb well tolerated in phase I trial in myeloma patients
Read More
Combination therapy with Myocet and Herceptin safe and effective in advanced breast cancer
Read More
Neurochem continues to build on success to date
Read More
Effects of new SERM on breast cancer and bone turnover biomarkers in women
Read More
Pregabalin safe and well tolerated as add-on therapy of partial seizures
Read More
Encouraging results from phase I/II trial of novel narcotic painkiller PTI-801
Read More
FDA gives go-ahead for HuMax-CD4 phase III trial in rheumatoid arthritis
Read More
SkyePharma and Astralis sign agreements for Psoraxine
Read More
Sankyo and Forest to copromote Benicar in U.S. for treatment of hypertension
Read More
Synergistic anticancer combinations identified at Schering-Plough
Read More
Tularik discovers new series of HCV polymerase inhibitors
Read More
Antitumor anthrapyridones claimed by Nippon Kayaku
Read More
Na+/K+-ATPase inhibitors and their use described by Yissum
Read More
ADIR scientists synthesize vitronectin receptor antagonist series
Read More
Idun presents new ICE/ced-3 inhibitors
Read More
Antiviral compounds targeting viral reverse transcriptase described by Dong Wha
Read More